These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 24039951

  • 1. Epigallocatechin-3-gallate inhibits stem-like inflammatory breast cancer cells.
    Mineva ND, Paulson KE, Naber SP, Yee AS, Sonenshein GE.
    PLoS One; 2013; 8(9):e73464. PubMed ID: 24039951
    [Abstract] [Full Text] [Related]

  • 2. (-)-Epigallocatechin-3-gallate inhibits growth of gastric cancer by reducing VEGF production and angiogenesis.
    Zhu BH, Zhan WH, Li ZR, Wang Z, He YL, Peng JS, Cai SR, Ma JP, Zhang CH.
    World J Gastroenterol; 2007 Feb 28; 13(8):1162-9. PubMed ID: 17451194
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Green tea polyphenol epigallocatechin-3-gallate inhibits the endothelin axis and downstream signaling pathways in ovarian carcinoma.
    Spinella F, Rosanò L, Di Castro V, Decandia S, Albini A, Nicotra MR, Natali PG, Bagnato A.
    Mol Cancer Ther; 2006 Jun 28; 5(6):1483-92. PubMed ID: 16818507
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Green tea polyphenol and epigallocatechin gallate induce apoptosis and inhibit invasion in human breast cancer cells.
    Thangapazham RL, Passi N, Maheshwari RK.
    Cancer Biol Ther; 2007 Dec 28; 6(12):1938-43. PubMed ID: 18059161
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inhibitory effects of epigallocatechin-3 gallate, a polyphenol in green tea, on tumor-associated endothelial cells and endothelial progenitor cells.
    Ohga N, Hida K, Hida Y, Muraki C, Tsuchiya K, Matsuda K, Ohiro Y, Totsuka Y, Shindoh M.
    Cancer Sci; 2009 Oct 28; 100(10):1963-70. PubMed ID: 19650861
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of tumour invasion and angiogenesis by epigallocatechin gallate (EGCG), a major component of green tea.
    Jung YD, Ellis LM.
    Int J Exp Pathol; 2001 Dec 28; 82(6):309-16. PubMed ID: 11846837
    [Abstract] [Full Text] [Related]

  • 12. (-)-Epigallocatechin-3-gallate inhibits VEGF expression induced by IL-6 via Stat3 in gastric cancer.
    Zhu BH, Chen HY, Zhan WH, Wang CY, Cai SR, Wang Z, Zhang CH, He YL.
    World J Gastroenterol; 2011 May 14; 17(18):2315-25. PubMed ID: 21633597
    [Abstract] [Full Text] [Related]

  • 13. Green tea epigallocatechin gallate shows a pronounced growth inhibitory effect on cancerous cells but not on their normal counterparts.
    Chen ZP, Schell JB, Ho CT, Chen KY.
    Cancer Lett; 1998 Jul 17; 129(2):173-9. PubMed ID: 9719459
    [Abstract] [Full Text] [Related]

  • 14. Suppression of Wnt signaling by the green tea compound (-)-epigallocatechin 3-gallate (EGCG) in invasive breast cancer cells. Requirement of the transcriptional repressor HBP1.
    Kim J, Zhang X, Rieger-Christ KM, Summerhayes IC, Wazer DE, Paulson KE, Yee AS.
    J Biol Chem; 2006 Apr 21; 281(16):10865-75. PubMed ID: 16495219
    [Abstract] [Full Text] [Related]

  • 15. The green tea polyphenol EGCG potentiates the antiproliferative activity of sunitinib in human cancer cells.
    Zhou Y, Tang J, Du Y, Ding J, Liu JY.
    Tumour Biol; 2016 Jul 21; 37(7):8555-66. PubMed ID: 26733173
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of green tea polyphenol EGCG((-)-epigallocatechin-3-gallate) on the proliferation of gastric cancer cells by suppressing canonical wnt/β-catenin signalling pathway.
    Yang C, Du W, Yang D.
    Int J Food Sci Nutr; 2016 Nov 21; 67(7):818-27. PubMed ID: 27338284
    [Abstract] [Full Text] [Related]

  • 17. Epigallocatechin-3-gallate inhibits the invasion of human oral cancer cells and decreases the productions of matrix metalloproteinases and urokinase-plasminogen activator.
    Ho YC, Yang SF, Peng CY, Chou MY, Chang YC.
    J Oral Pathol Med; 2007 Nov 21; 36(10):588-93. PubMed ID: 17944751
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. EGCG inhibits proliferation, invasiveness and tumor growth by up-regulation of adhesion molecules, suppression of gelatinases activity, and induction of apoptosis in nasopharyngeal carcinoma cells.
    Fang CY, Wu CC, Hsu HY, Chuang HY, Huang SY, Tsai CH, Chang Y, Tsao GS, Chen CL, Chen JY.
    Int J Mol Sci; 2015 Jan 23; 16(2):2530-58. PubMed ID: 25625511
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.